After positive results with apes last May, two types of vaccines will be sent to San Diego (United States) and Vancuver (in Canada), to produce 10,000 doses by November
Bangkok.- A team of researchers from Thailand will start testing with humans of a vaccine against COVID-19 around the next month of November, which if successful, could be distributed next year, according to team members announced this Sunday.
After positive results with apes last May, two types of vaccines will be sent to San Diego (United States) and Vancuver (in Canada), to produce 10,000 doses for NovemberKiat Ruxrungtham, director of the Vaccine Research Center at Chulalongkorn University in Bangkok, said at a press conference.
The vaccine, developed in collaboration with a team from the University of Pennsylvania, in the United States, will be tested in a first phase on about a hundred people divided into two groups: first, different doses will be inoculated into a group of individuals between 18 and 60 years of age. and then to another group with ages between 60 and 80.
If the results of the first phase are positive, it will go to a second phase, in which the sample will be expanded to between 500 and 1,000 people.
At the moment, the team of researchers does not accept volunteers, since the tests are pending approval by the relevant authorities, but if they were crowned with success, it is expected that the company BioNet Asia could produce the vaccine at a massive level from the third or fourth quarter of 2021.
Thailand was the first country to detect a case of COVID-19 Outside of China, the epicenter of the pandemic, but so far it has managed to contain it by closing borders and using masks extensively, with 3,217 confirmed cases and 58 deaths.